{"name":"PathAI","slug":"pathai","ticker":"PRIVATE","exchange":"Private","domain":"pathai.com","description":"PathAI is a private company specializing in AI-powered pathology and diagnostics. They focus on developing innovative solutions for disease diagnosis and treatment. Their key products are AI-powered diagnostic tools for various diseases. As a private company, PathAI does not publicly disclose its financial information, but it has received significant funding from investors.","hq":"Boston, MA","founded":0,"employees":"","ceo":"Andy Beck","sector":"AI-Powered Pathology & Diagnostics","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"~$800M (last private valuation)","metrics":{"revenue":50000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"deal","headline":"PathAI Raises $100M in Series C Funding","summary":"PathAI has raised $100 million in Series C funding to accelerate the development of its AI-powered diagnostic tools.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"PathAI Partners with Leading Healthcare Provider","summary":"PathAI has partnered with a leading healthcare provider to integrate its AI-powered diagnostic tools into their clinical workflows.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNVWNGTG9zaHZDTG9RbEJoQ1E5TldqRE9mWG1XbDV1aENPMGlRUHlpbjdjNW5Za2lxcnFFT3g4dTNZTHNLRkRGclB3QnNnOC1SQjNrQUhOVVhFVlE0ZUI2MkZTcklCOVFtbHN6dVFNdk9aNm5GdG1hZFVvRjNfbElHdmV6dzR6RWVOQzlVX1phbw?oc=5","date":"2023-08-21","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Techbio landscape: Insights into AI and genomics in pharma - drugdiscoverytrends.com","headline":"Techbio landscape: Insights into AI and genomics in pharma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["DeepMind","IBM Watson Health","Nuance Communications"],"therapeuticFocus":["Cancer diagnosis","Disease diagnosis"],"financials":null,"yahoo":null}